{"id":"W4315778614","doi":"10.1101/2023.01.11.23284254","title":"Garetosmab, an inhibitor of activin A, reduces heterotopic ossification and flare-ups in adults with fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial","year":2023,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Heterotopic Ossification and Related Conditions","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"Regeneron Pharmaceuticals; University of Pennsylvania; Vanderbilt University Medical Center; Vanderbilt University","keywords":"Fibrodysplasia ossificans progressiva; Placebo; Medicine; Clinical endpoint; Tolerability; Adverse effect; Heterotopic ossification; Internal medicine; Randomized controlled trial; Surgery; Urology; Gastroenterology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001239904,0.000566253,0.002200945,0.0008512512,0.0001297175,0.0001210307,0.000276229,0.0007840073,0.00008785869],"category_scores_gemma":[0.0004214129,0.0004039384,0.0003357493,0.0004271641,0.0005623084,0.0001781179,0.00009729443,0.001210464,0.00001120251],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001063472,"about_ca_system_score_gemma":0.0006121357,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009894989,"about_ca_topic_score_gemma":0.00009090143,"domain_scores_codex":[0.9954971,0.0006739919,0.001647566,0.001132078,0.0006294042,0.0004198602],"domain_scores_gemma":[0.9968861,0.000396861,0.001094809,0.001002656,0.0002815156,0.0003380469],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9884561,0.001482923,0.001166436,0.0007026299,0.0005665356,0.00006736119,0.002736403,0.00002059255,0.002750128,0.00008728258,0.00002216672,0.001941476],"study_design_scores_gemma":[0.985059,0.001095476,0.001526957,0.002888225,0.0006460444,0.00003207057,0.0005136239,0.002089249,0.005610905,0.00008336594,0.00005779462,0.000397282],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9754715,0.0002211791,0.0001470307,0.001609341,0.0006240274,0.02131394,0.00007007212,0.0002075921,0.0003353351],"genre_scores_gemma":[0.9858589,0.0002211082,0.000313433,0.00001717863,0.0004612628,0.01161652,0.000573412,0.00007873498,0.0008594434],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01038743,"threshold_uncertainty_score":0.9998413,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05090562283686747,"score_gpt":0.3499890616480531,"score_spread":0.2990834388111857,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}